Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access

By /

Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options to the ALS community.

Scroll to Top